
RWAY vs DRUG
$RWAY vs $DRUG head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RWAY vs DRUG: the quick read
- ·RWAY is the larger company by market cap ($280M vs $276M).
- ·RWAY has been more active on our scanner (12 vs 7 alerts in 30 days).
- ·DRUG has the smaller float (4.5M vs 41.5M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (UNKNOWN vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·RWAY trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 12 and 7 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·RWAY pays a dividend and DRUG does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RWAY and DRUG on TheDesperateTrader.
- Is RWAY or DRUG the better stock?
- "Better" depends on your goal, and these two are not alike. RWAY is the larger company by market cap ($280M vs $276M). RWAY has been more active on our scanner (12 vs 7 alerts in 30 days). DRUG has the smaller float (4.5M vs 41.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RWAY and DRUG?
- The differences that matter: they are not in the same business - RWAY is unknown and DRUG is pharmaceutical preparations; they are similar in size ($280M vs $276M); they trade at very different share prices ($6.69 vs $60.98); RWAY sits at 27% of its 52-week range against 21% for DRUG; only RWAY pays a dividend; our scanner flagged RWAY 12 times in the last 30 days against 7 for DRUG. Everything above is measured from the latest completed session and SEC filings.
- Which of RWAY and DRUG is more active right now?
- Right now RWAY is at about 0.4x its normal volume and DRUG is at about 1.2x, so DRUG is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RWAY or DRUG? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.